Literature DB >> 11851579

Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant.

Abigail Freedman1, Olubunmi Afonja, Mary Wu Chang, Farzad Mostashari, Martin Blaser, Guillermo Perez-Perez, Herb Lazarus, Robert Schacht, Jane Guttenberg, Michael Traister, William Borkowsky.   

Abstract

A 7-month-old infant with cutaneous anthrax developed severe systemic illness despite early treatment with antibiotics. The infant displayed severe microangiopathic hemolytic anemia with renal involvement, coagulopathy, and hyponatremia. These findings are unusual with cutaneous anthrax, but have been described in illness resulting from spider toxin and may delay correct diagnosis. The systemic manifestations of the disease persisted for nearly a month despite corticosteroid therapy, but resolved.

Entities:  

Mesh:

Year:  2002        PMID: 11851579     DOI: 10.1001/jama.287.7.869

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  18 in total

Review 1.  Hospital planning for acts of terrorism and other public health emergencies involving children.

Authors:  S Chung; M Shannon
Journal:  Arch Dis Child       Date:  2005-12       Impact factor: 3.791

2.  Pathophysiological manifestations in mice exposed to anthrax lethal toxin.

Authors:  Nathan C Culley; David M Pinson; Anuradha Chakrabarty; Matthew S Mayo; Steven M LeVine
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Educating health professionals to respond to bioterrorism.

Authors:  W Paul McKinney; Gina C Wesley; Mary V Sprang; Adewale Troutman
Journal:  Public Health Rep       Date:  2005       Impact factor: 2.792

4.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling.

Authors:  Narcis Ioan Popescu; Alanson Girton; Tarea Burgett; Kessa Lovelady; K Mark Coggeshall
Journal:  Blood Adv       Date:  2019-08-27

6.  Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies.

Authors:  Karina Ramirez; Yanina Ditamo; James E Galen; Les W J Baillie; Marcela F Pasetti
Journal:  Vaccine       Date:  2010-07-07       Impact factor: 3.641

Review 7.  Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review.

Authors:  Satish K Pillai; Eileen Huang; Julie T Guarnizo; Jamechia D Hoyle; Stefan Katharios-Lanwermeyer; Theresa K Turski; William A Bower; Katherine A Hendricks; Dana Meaney-Delman
Journal:  Health Secur       Date:  2015-12-01

Review 8.  An approach to spider bites. Erroneous attribution of dermonecrotic lesions to brown recluse or hobo spider bites in Canada.

Authors:  Robert G Bennett; Richard S Vetter
Journal:  Can Fam Physician       Date:  2004-08       Impact factor: 3.275

9.  The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax.

Authors:  Wun-Ju Shieh; Jeannette Guarner; Christopher Paddock; Patricia Greer; Kathleen Tatti; Marc Fischer; Marci Layton; Michael Philips; Eddy Bresnitz; Conrad P Quinn; Tanja Popovic; Bradley A Perkins; Sherif R Zaki
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.

Authors:  Vincent P Hsu; Susan L Lukacs; Thomas Handzel; James Hayslett; Scott Harper; Thomas Hales; Vera A Semenova; Sandra Romero-Steiner; Cheryl Elie; Conrad P Quinn; Rima Khabbaz; Ali S Khan; Gregory Martin; John Eisold; Anne Schuchat; Rana A Hajjeh
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.